Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 28;14(1):99-105.
doi: 10.3390/pediatric14010015.

Maternal Risk Factors Triggering Congenital Heart Defects in Down Syndrome: A Case-Control Study

Ambreen Asim  1 , Sarita Agarwal  1 , Deepika Delsa Dean  1
Affiliations

Maternal Risk Factors Triggering Congenital Heart Defects in Down Syndrome: A Case-Control Study

Ambreen Asim et al. Pediatr Rep. .

Abstract

Objectives: Maternal MTHFR and MTRR polymorphisms as a risk of CHD in DS fetus were studied along with maternal folic acid supplementation, which could influence the folate metabolism along with other risk factors.

Material and methods: A case-control study comprising of mothers of DS with and without CHD along with controls were recruited from a tertiary care center since 2018-2019. Genomic DNA was isolated followed by PCR-RFLP.

Results: Mothers with age ≥35 years and having history of miscarriages have a higher risk of giving birth to DS with CHD (n = 35% and 42%, respectively). Mothers who carried the MTHFR 677CT/TT and MTRR 524CT/TT genotypes combination in the folic acid nonusers group during pregnancies had six-fold (OR = 6.909, p-value = 0.027; 95% CI-1.23 ± 38.51) and four-fold (OR = 4.75, p-value = 0.040; 95% CI-1.067 ± 21.44) increased odds of having a DS child with CHD, respectively, as compared to folic acid users.

Conclusion: Maternal age, folic acid supplementation, and previous history of miscarriages is involved in the etiology of CHD in DS fetus in Indian population. Maternal MTHFR and MTRR polymorphisms are also involved in the occurrence of CHD and DS in Indian population when controlling for periconceptional folic acid supplementation.

Limitations: Single-Centered Study.

Keywords: Down syndrome; MTHFR; MTRR; congenital heart defects.

PubMed Disclaimer

Conflict of interest statement

No conflict of interest was declared by the authors.

Similar articles

See all similar articles

Cited by

References

    1. Asim A., Ashok K., Srinivasan M., Shalu J., Sarita A. Down syndrome: An insight of the disease. J. Biomed. Sci. 2015;22:41. doi: 10.1186/s12929-015-0138-y. - DOI - PMC - PubMed
    1. Mourato F.A., Villachan L.R.R., de Silva Mattos S. Prevalence and profile of congenital heart disease and pulmonary hypertension in Down syndrome in a pediatric cardiology service. Rev. Paul. Pediatr. 2014;32:159–163. doi: 10.1590/0103-0582201432218913. - DOI - PMC - PubMed
    1. Bermudez B.E.B.V., Medeiros S.L., Bermudez M.B., Novadzki I.M., Magdalena N.I.R. Down syndrome: Prevalence and distribution of congenital heart disease in Brazil. São Paulo Med. J. 2015;133:621–624. doi: 10.1590/1516-3180.2015.00710108. - DOI - PMC - PubMed
    1. Bergstrom S., Carr H., Ptereson G., Stephansson O., Bonamy A.K.E., Dahlström A., Halvorsen C.P., Johansson S. Trends in congenital heart defects in infants with Down syndrome. Pediatrics. 2016;138:e20160123. doi: 10.1542/peds.2016-0123. - DOI - PubMed
    1. Wu J., Morris J.K. Trends in maternal age distribution and the live birth prevalence of Down’s syndrome in England and Wales: 1938–2010. Eur. J. Hum. Genet. 2013;21:943–947. doi: 10.1038/ejhg.2012.288. - DOI - PMC - PubMed

LinkOut - more resources